15 December 2022

Exercise Pain Reactive Arthritis

Exercise in lupus: safe, useful, but uncommon

1 December 2022

Reactive Arthritis

Lupus research highlights from ACR

14 November 2022

Reactive Arthritis Spondyloarthritis

Secrets, myths and pearls

10 November 2022

Case study Reactive Arthritis Rheumatoid Arthritis

A painless clicking ankle

6 October 2022

Polymyalgia Rheumatica Reactive Arthritis Research Sex

Sex and gender in rheumatology: Summit roundup

29 September 2022

Reactive Arthritis Research

Encouraging results from early lupus drug trial

29 September 2022

Dermatology Reactive Arthritis

Confirmation of PPI and lupus link

21 September 2022

Biologics Reactive Arthritis

Reducing risk of HCQ retinopathy comes at a cost

20 September 2022

Reactive Arthritis Research

CAR T-cell therapy shows promise in lupus

1 September 2022

COVID-19 Reactive Arthritis

The lupus pain in Spain stays mainly when over target again

22 August 2022

PBS Reactive Arthritis

Anifrolumab hits PBAC roadblock

9 June 2022

Reactive Arthritis

Lupus hope found in psoriasis and cancer drugs

6 June 2022

Reactive Arthritis

Viral and fungal infections take over as key opportunistic diseases

6 June 2022

Pharmacy Guild of Australia Polymyalgia Rheumatica Reactive Arthritis

EULAR highlights

31 March 2022

COVID-19 Reactive Arthritis Rheumatoid Arthritis Technology

Tripling paeds rheum positions among inquiry recommendations

24 March 2022

Reactive Arthritis Spondyloarthritis

ANA and RF in direct-to-consumer free-for-all